Intra-Cellular Therapies unveils new data on CAPLYTA at ACNP annual meeting
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, announced presentations at the 63rd Annual Meeting of… read more.